Exagen Inc
NASDAQ:XGN

Watchlist Manager
Exagen Inc Logo
Exagen Inc
NASDAQ:XGN
Watchlist
Price: 6.19 USD -2.06% Market Closed
Market Cap: 140.3m USD

Wall Street
Price Targets

XGN Price Targets Summary
Exagen Inc

Wall Street analysts forecast XGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XGN is 15.74 USD with a low forecast of 12.12 USD and a high forecast of 18.9 USD.

Lowest
Price Target
12.12 USD
96% Upside
Average
Price Target
15.74 USD
154% Upside
Highest
Price Target
18.9 USD
205% Upside
Exagen Inc Competitors:
Price Targets
PHARM
Pharming Group NV
45% Upside
688382
InventisBio Co Ltd
72% Upside
STOK
Stoke Therapeutics Inc
3% Upside
UTHR
United Therapeutics Corp
1% Upside
EXEL
Exelixis Inc
1% Downside
GILD
Gilead Sciences Inc
8% Upside
PHIL
Philogen SpA
13% Upside
GNFT
Genfit SA
71% Upside

Revenue
Forecast

Revenue Estimate
Exagen Inc

For the last 11 years the compound annual growth rate for Exagen Inc's revenue is 30%. The projected CAGR for the next 4 years is 16%.

30%
Past Growth
16%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Exagen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Exagen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XGN's stock price target?
Price Target
15.74 USD

According to Wall Street analysts, the average 1-year price target for XGN is 15.74 USD with a low forecast of 12.12 USD and a high forecast of 18.9 USD.

What is Exagen Inc's Revenue forecast?
Projected CAGR
16%

For the last 11 years the compound annual growth rate for Exagen Inc's revenue is 30%. The projected CAGR for the next 4 years is 16%.

Back to Top